Endogenous marinobufagenin-like factor in acute plasma volume expansion

被引:95
作者
Fedorova, OV
Doris, PA
Bagrov, AY
机构
[1] NIA, Cardiovasc Sci Lab, Baltimore, MD 21224 USA
[2] IM Sechenov Evolutionary Physiol & Biochem Inst, St Petersburg 194223, Russia
[3] Univ Texas, Hlth Sci Ctr, Inst Mol Med, Houston, TX 77030 USA
关键词
Na/K ATPase; ouabain; marinobufagenin; plasma; pituitary; volume expansion; dog; rat;
D O I
10.3109/10641969809053236
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of the study was to further investigate the nature of endogenous digitalis-like factors stimulated by acute plasma volume expansion (VE). 10 male Fisher 344XNB rats were given intravenous (iv) saline infusion (4% of the body mass) for 30 min, which caused a fall in % hematocrit (35.9+/-0.69 vs. 41.8+/-1.05; vs. 10 controls, P<0.01). EDLF was measured in C-18 reverse-phase extracted (32%+/-80% acetonitrile) tissues. VE was associated with an increase in plasma marinobufagenin-like factor (MLF)(0.49+/-0.05 vs. 0.2+/-0.06 nmol/L, P<0.01) and pituitary ouabain-like compound (OLC) (30.9+/-3.12 vs. 3.2+/-2.3 pmol/g, P<0.01). Plasma OLC decreased (0.087+/-0.018 vs. 0.21+/-0.04 nmol/L, P<0.02), and pituitary MLF did not change (0.05+/-0.01 vs. 0.07+/-0.02 pmol/g) after VE. Chloroform extracted urine from 5 volume-expanded male mongrel dogs was fractionated on reverse-phase HPLC columns in a linear gradient of 0-80% acetonitrile. The material cross-reacting with marinobufagenin antibody eluted from HPLC column as a single peak, demonstrated absorbance at 300 nm, and was distinct from ouabain-like material. Digoxin antibodies interacted with both marinobufagenin-like and ouabain-like immunoreactive material. These results provide further evidence for the presence of a bufodienolide EDLF in the mammals, and demonstrate that EDLF response to VE includes stimulation of brain OLC and plasma bufodienolide.
引用
收藏
页码:581 / 591
页数:11
相关论文
共 26 条
  • [1] Endogenous marinobufagenin-like immunoreactive substance - A possible endogenous Na,K-ATPase inhibitor with vasoconstrictor activity
    Bagrov, AY
    Dmitrieva, RI
    Fedorova, OV
    Kazakov, GP
    Roukoyatkina, NI
    Shpen, VM
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 1996, 9 (10) : 982 - 990
  • [2] ENDOGENOUS MARINOBUFAGENIN-LIKE IMMUNOREACTIVE FACTOR AND NA+,K+ ATPASE INHIBITION DURING VOLUNTARY HYPOVENTILATION
    BAGROV, AY
    FEDOROVA, OV
    AUSTINLANE, JL
    DMITRIEVA, RI
    ANDERSON, DE
    [J]. HYPERTENSION, 1995, 26 (05) : 781 - 788
  • [3] EFFECTS OF 2 ENDOGENOUS NA+,K+-ATPASE INHIBITORS, MARINOBUFAGENIN AND OUABAIN, ON ISOLATED RAT AORTA
    BAGROV, AY
    ROUKOYATKINA, NI
    PINAEV, AG
    DMITRIEVA, RI
    FEDOROVA, OV
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 274 (1-3) : 151 - 158
  • [4] Bagrov AY, 1996, CARDIOVASC RES, V31, P296
  • [5] BAGROV AY, 1996, AM J HYPERTENS, V9, pA133
  • [6] DIE BUFOGENINE DES PARATOIDENSEKRETES VON BUFO-MARINUS (L) SCHNEIDER UBER KROTENGIFTE .21.
    BARBIER, M
    SCHROTER, H
    MEYER, K
    SCHINDLER, O
    REICHSTEIN, T
    [J]. HELVETICA CHIMICA ACTA, 1959, 42 (07) : 2486 - 2505
  • [7] PHARMACOLOGY AND TOXICOLOGY OF TOAD VENOM
    CHEN, KK
    KOVARIKOVA, A
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1967, 56 (12) : 1535 - +
  • [8] DORIS PA, 1994, P SOC EXP BIOL MED, V205, P202
  • [9] OUABAIN IN PLASMA FROM SPONTANEOUSLY HYPERTENSIVE RATS
    DORIS, PA
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (01): : H360 - H364
  • [10] HEMODYNAMIC-EFFECTS OF BUFALIN IN THE ANESTHETIZED DOG
    ELIADES, D
    SWINDALL, B
    JOHNSTON, J
    PAMNANI, M
    HADDY, F
    [J]. HYPERTENSION, 1989, 13 (06) : 690 - 695